179 related articles for article (PubMed ID: 7553653)
1. Differentiation of neuroblastoma enhances Bcl-2 expression and induces alterations of apoptosis and drug resistance.
Lasorella A; Iavarone A; Israel MA
Cancer Res; 1995 Oct; 55(20):4711-6. PubMed ID: 7553653
[TBL] [Abstract][Full Text] [Related]
2. HMGI(Y) and HMGI-C genes are expressed in neuroblastoma cell lines and tumors and affect retinoic acid responsiveness.
Giannini G; Di Marcotullio L; Ristori E; Zani M; Crescenzi M; Scarpa S; Piaggio G; Vacca A; Peverali FA; Diana F; Screpanti I; Frati L; Gulino A
Cancer Res; 1999 May; 59(10):2484-92. PubMed ID: 10344762
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation.
Ponzoni M; Bocca P; Chiesa V; Decensi A; Pistoia V; Raffaghello L; Rozzo C; Montaldo PG
Cancer Res; 1995 Feb; 55(4):853-61. PubMed ID: 7850799
[TBL] [Abstract][Full Text] [Related]
4. Bcl-2 is a key regulator for the retinoic acid-induced apoptotic cell death in neuroblastoma.
Niizuma H; Nakamura Y; Ozaki T; Nakanishi H; Ohira M; Isogai E; Kageyama H; Imaizumi M; Nakagawara A
Oncogene; 2006 Aug; 25(36):5046-55. PubMed ID: 16568081
[TBL] [Abstract][Full Text] [Related]
5. Induction of transforming growth factor beta 1 and its receptors during all-trans-retinoic acid (RA) treatment of RA-responsive human neuroblastoma cell lines.
Cohen PS; Letterio JJ; Gaetano C; Chan J; Matsumoto K; Sporn MB; Thiele CJ
Cancer Res; 1995 Jun; 55(11):2380-6. PubMed ID: 7757990
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Bcl-2 oncoprotein levels with differentiation of human neuroblastoma cells.
Hanada M; Krajewski S; Tanaka S; Cazals-Hatem D; Spengler BA; Ross RA; Biedler JL; Reed JC
Cancer Res; 1993 Oct; 53(20):4978-86. PubMed ID: 8402688
[TBL] [Abstract][Full Text] [Related]
7. Retinoic acid-induced growth arrest and differentiation of neuroblastoma cells are counteracted by N-myc and enhanced by max overexpressions.
Peverali FA; Orioli D; Tonon L; Ciana P; Bunone G; Negri M; Della-Valle G
Oncogene; 1996 Jan; 12(2):457-62. PubMed ID: 8570225
[TBL] [Abstract][Full Text] [Related]
8. The expression of multiple proto-oncogenes is differentially regulated during retinoic acid induced maturation of human neuroblastoma cell lines.
Thiele CJ; Deutsch LA; Israel MA
Oncogene; 1988 Sep; 3(3):281-8. PubMed ID: 3060792
[TBL] [Abstract][Full Text] [Related]
9. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells.
Elstner E; Linker-Israeli M; Umiel T; Le J; Grillier I; Said J; Shintaku IP; Krajewski S; Reed JC; Binderup L; Koeffler HP
Cancer Res; 1996 Aug; 56(15):3570-6. PubMed ID: 8758928
[TBL] [Abstract][Full Text] [Related]
10. Bcl-2 expression in neuroblastoma is differentially regulated by differentiation inducers.
Kim CJ; Kim HO; Choe YJ; Lee YA; Kim CW
Anticancer Res; 1995; 15(5B):1997-2000. PubMed ID: 8572591
[TBL] [Abstract][Full Text] [Related]
11. Persistent human cytomegalovirus infection induces drug resistance and alteration of programmed cell death in human neuroblastoma cells.
Cinatl J; Cinatl J; Vogel JU; Kotchetkov R; Driever PH; Kabickova H; Kornhuber B; Schwabe D; Doerr HW
Cancer Res; 1998 Jan; 58(2):367-72. PubMed ID: 9443419
[TBL] [Abstract][Full Text] [Related]
12. Alpha-tocopheryl succinate selectively induces apoptosis in neuroblastoma cells: potential therapy of malignancies of the nervous system?
Swettenham E; Witting PK; Salvatore BA; Neuzil J
J Neurochem; 2005 Sep; 94(5):1448-56. PubMed ID: 16001965
[TBL] [Abstract][Full Text] [Related]
13. Bcl-xL is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis.
Dole MG; Jasty R; Cooper MJ; Thompson CB; Nuñez G; Castle VP
Cancer Res; 1995 Jun; 55(12):2576-82. PubMed ID: 7780971
[TBL] [Abstract][Full Text] [Related]
14. Effects of retinoic acid on proliferation, apoptosis, cytotoxicity, migration, and invasion of neuroblastoma cells.
Voigt A; Zintl F
Med Pediatr Oncol; 2003 Apr; 40(4):205-13. PubMed ID: 12555246
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of staurosporine and retinoic acid on the vulnerability of the SH-SY5Y neuroblastoma cells: involvement of bcl-2 and p53 proteins.
Tieu K; Zuo DM; Yu PH
J Neurosci Res; 1999 Nov; 58(3):426-35. PubMed ID: 10518116
[TBL] [Abstract][Full Text] [Related]
16. BMP-6 and retinoic acid synergistically differentiate the IMR-32 human neuroblastoma cells.
Sumantran VN; Brederlau A; Funa K
Anticancer Res; 2003; 23(2B):1297-303. PubMed ID: 12820386
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines.
Henkels KM; Turchi JJ
Cancer Res; 1999 Jul; 59(13):3077-83. PubMed ID: 10397248
[TBL] [Abstract][Full Text] [Related]
18. Ectopic expression of DAN enhances the retinoic acid-induced neuronal differentiation in human neuroblastoma cell lines.
Nakamura Y; Ozaki T; Ichimiya S; Nakagawara A; Sakiyama S
Biochem Biophys Res Commun; 1998 Feb; 243(3):722-6. PubMed ID: 9500977
[TBL] [Abstract][Full Text] [Related]
19. The effects of retinoic acid on the in vitro and in vivo growth of neuroblastoma cells.
Abemayor E
Laryngoscope; 1992 Oct; 102(10):1133-49. PubMed ID: 1328787
[TBL] [Abstract][Full Text] [Related]
20. Distinct mechanisms of cell cycle arrest control the decision between differentiation and senescence in human neuroblastoma cells.
Wainwright LJ; Lasorella A; Iavarone A
Proc Natl Acad Sci U S A; 2001 Jul; 98(16):9396-400. PubMed ID: 11481496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
